Richard Russell

4.7k total citations · 1 hit paper
64 papers, 2.2k citations indexed

About

Richard Russell is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Richard Russell has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 32 papers in Physiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Richard Russell's work include Chronic Obstructive Pulmonary Disease (COPD) Research (40 papers), Asthma and respiratory diseases (32 papers) and Respiratory Support and Mechanisms (14 papers). Richard Russell is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (40 papers), Asthma and respiratory diseases (32 papers) and Respiratory Support and Mechanisms (14 papers). Richard Russell collaborates with scholars based in United Kingdom, United States and Australia. Richard Russell's co-authors include Peter J. Barnes, Louise Donnelly, Sarah V. Culpitt, Duncan F. Rogers, John Wiggins, Michael F. Smith, Peter Fenwick, Robert Newton, Pallav L. Shah and Kazuhiro Ito and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Richard Russell

63 papers receiving 2.1k citations

Hit Papers

Development and validation of a new algorithm for improve... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Development and validation of a new algorithm for improved cardiovascular risk prediction
    2024 52 citations Mona Bafadhel, Richard Russell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Russell United Kingdom 17 1.2k 866 399 284 229 64 2.2k
Adam Barczyk Poland 17 1.1k 0.9× 898 1.0× 476 1.2× 469 1.7× 307 1.3× 80 2.0k
Kazuto Matsunaga Japan 31 1.5k 1.3× 1.4k 1.6× 391 1.0× 444 1.6× 132 0.6× 149 2.7k
So Ri Kim South Korea 33 786 0.7× 784 0.9× 1.0k 2.6× 647 2.3× 89 0.4× 115 3.0k
Juanita H. J. Vernooy Netherlands 25 1.2k 1.0× 749 0.9× 416 1.0× 514 1.8× 162 0.7× 37 2.3k
Richa Singh India 24 756 0.6× 348 0.4× 766 1.9× 108 0.4× 93 0.4× 72 2.0k
Pawan Sharma United States 27 510 0.4× 592 0.7× 770 1.9× 198 0.7× 50 0.2× 77 2.1k
Girolamo Pelaia Italy 41 2.1k 1.7× 2.6k 3.0× 606 1.5× 843 3.0× 236 1.0× 149 4.4k
Shuichiro Maruoka Japan 30 762 0.6× 902 1.0× 823 2.1× 688 2.4× 110 0.5× 85 2.7k
P. L. B. Bruijnzeel Netherlands 27 931 0.8× 742 0.9× 234 0.6× 492 1.7× 43 0.2× 59 2.5k

Countries citing papers authored by Richard Russell

Since Specialization
Citations

This map shows the geographic impact of Richard Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Russell more than expected).

Fields of papers citing papers by Richard Russell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Russell. The network helps show where Richard Russell may publish in the future.

Co-authorship network of co-authors of Richard Russell

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Russell. A scholar is included among the top collaborators of Richard Russell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Russell. Richard Russell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ramakrishnan, Sanjay, Richard Russell, & Mona Bafadhel. (2025). Treating Eosinophilic Exacerbations of Airways Disease With Benralizumab Reduces Cumulative Systemic Corticosteroid Exposure at 90 Days. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5233–A5233.
3.
4.
Nicolau, Dan V., Christine Mwasuku, Sanjay Ramakrishnan, et al.. (2024). Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19. ERJ Open Research. 10(3). 919–2023. 2 indexed citations
5.
Gao, Zhiwei, Jennifer K Quint, Richard Russell, et al.. (2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. 79(8). 718–724. 13 indexed citations
6.
Taylor, Stephanie, Marko Topalovic, Richard Russell, et al.. (2023). Spirometry services in England post-pandemic and the potential role of AI support software: a qualitative study of challenges and opportunities. British Journal of General Practice. 73(737). e915–e923. 12 indexed citations
7.
Geßner, Christian, Richard Russell, Detlef Nachtigall, et al.. (2023). Impact of extrafine formulation single-inhaler triple therapy on lung function after three months of treatment in patients with asthma: the TriMaximize study. PA2379–PA2379. 1 indexed citations
8.
Russell, Richard, George B. Cunningham, Maarten De Vos, et al.. (2022). Performance of cough monitoring by Albus Home, a contactless and automated system for nocturnal respiratory monitoring at home. ERJ Open Research. 8(4). 265–2022. 8 indexed citations
9.
10.
Baker, Jonathan, Mahdi Mahdi, Dan V. Nicolau, et al.. (2022). Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. The Lancet Respiratory Medicine. 10(6). 545–556. 33 indexed citations
11.
Wise, Robert A., Mona Bafadhel, Courtney Crim, et al.. (2021). Discordant diagnostic criteria for pneumonia in COPD trials: a review. European Respiratory Review. 30(162). 210124–210124. 8 indexed citations
12.
Black, Jim, et al.. (2020). Are convergence lines associated with high asthma presentation days? A case-control study in Melbourne, Australia. The Science of The Total Environment. 737. 140263–140263. 11 indexed citations
13.
Russell, Richard, et al.. (2019). <p>The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD</p>. International Journal of COPD. Volume 14. 971–977. 7 indexed citations
14.
Shrimanker, Rahul, et al.. (2016). Defining Inflammatory Groups Within A COPD Cohort. American Journal of Respiratory and Critical Care Medicine. 193. 1 indexed citations
15.
Brightling, Christopher E., et al.. (2016). The Blood Eosinophil Trajectory Of Patients With COPD Through Stable State, Exacerbation And Recovery. American Journal of Respiratory and Critical Care Medicine. 193. 1 indexed citations
16.
Russell, Sarah & Richard Russell. (2007). Challenges in end-of-life communication in COPD. Breathe. 4(2). 133–139. 4 indexed citations
17.
Cantillon, Marc, et al.. (2005). Preliminary safety, tolerability and efficacy of ALGRX 4975 in Osteoarthritis (OA) of the knee. Journal of Pain. 6(3). S39–S39. 6 indexed citations
18.
Culpitt, Sarah V., Duncan F. Rogers, Pallav L. Shah, et al.. (2002). Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 167(1). 24–31. 251 indexed citations
19.
Culpitt, Sarah V., et al.. (2002). Effect of Theophylline on Induced Sputum Inflammatory Indices and Neutrophil Chemotaxis in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 165(10). 1371–1376. 128 indexed citations
20.
Russell, Richard, Sarah V. Culpitt, Louise Donnelly, et al.. (2002). Release and Activity of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 26(5). 602–609. 349 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Barczyk Breakdown of academic impact, for papers by Kazuto Matsunaga Breakdown of academic impact, for papers by So Ri Kim Breakdown of academic impact, for papers by Juanita H. J. Vernooy Breakdown of academic impact, for papers by Richa Singh Breakdown of academic impact, for papers by Pawan Sharma Breakdown of academic impact, for papers by Girolamo Pelaia Breakdown of academic impact, for papers by Shuichiro Maruoka Breakdown of academic impact, for papers by P. L. B. Bruijnzeel
Rankless by CCL
2026